Exact Mass: 278.0321

Exact Mass Matches: 278.0321

Found 54 metabolites which its exact mass value is equals to given mass value 278.0321, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Alcophosphamide

3-({amino[bis(2-chloroethyl)amino]phosphoryl}oxy)propan-1-ol

C7H17Cl2N2O3P (278.0354)

Detoxification of cyclophosphamide is effected, in part, by hepatic class 1 aldehyde dehydrogenase (ALDH-1)-catalyzed oxidation of aldophosphamide, a pivotal aldehyde intermediate, to the nontoxic metabolite, carboxyphosphamide. Detoxification of aldophosphamide may also be effected by enzymes, viz. Thus, NAD-linked oxidation and NADPH-linked reduction of aldophosphamide catalyzed by relevant erythrocyte enzymes were quantified. (PMID: 9394035) It has already been demonstrated that horse liver alcohol dehydrogenase catalyzes the reduction of aldophosphamide to alcophosphamide. (PMID: 8216347) D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards

Alcoifosfamide

3-({bis[(2-chloroethyl)amino]phosphoryl}oxy)propan-1-ol

C7H17Cl2N2O3P (278.0354)

Alcoifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated IFO. (Wikipedia)

Cyclophosphamide monohydrate

C7H17Cl2N2O3P (278.0354)

D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D010752 - Phosphoramide Mustards C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D019653 - Myeloablative Agonists D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000477 - Alkylating Agents D009676 - Noxae > D009153 - Mutagens D018501 - Antirheumatic Agents

(1,1-Diamino-4-sulfamoyloxybutyl) sulfamate

(1,1-Diamino-4-sulphamoyloxybutyl) sulphamic acid

C4H14N4O6S2 (278.0355)

4',6-Dichloroflavan

6-chloro-2-(4-chlorophenyl)-3,4-dihydro-2H-1-benzopyran

C15H12Cl2O (278.0265)

Benzyl trisulfide

Dibenzyl trisulfide

C14H14S3 (278.0258)

Harmol sulfate

{1-methyl-9H-pyrido[3,4-b]indol-7-yl}oxidanesulfonic acid

C12H10N2O4S (278.0361)

2-(4-Chlorophenyl)-1-(2,4,6-trihydroxyphenyl)ethanone

C14H11ClO4 (278.0346)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.081 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.080

Benzyl trisulfide

Dibenzyl trisulfide

C14H14S3 (278.0258)

MLS001306483-01!Cytoxan6055-19-2

C7H17Cl2N2O3P (278.0354)

CAY10464

1,3-dichloro-5-[(1E)-2-(4-methoxyphenyl)ethenyl]-benzene

C15H12Cl2O (278.0265)

5-(hexa-5-en-1,3-diyn-1-yl)-5-(prop-1-yn-1-yl)-2,2-bithiophene

C17H10S2 (278.0224)

Acecarbromal

acetyl carbromal

C9H15BrN2O3 (278.0266)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor